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Background: Single incision thoracoscopic surgery (SITS) is recognized as a difficult procedure and surgeons
hesitate to perform this technique. We describe our experience of SITS and determine whether SITS can be a
routine approach in minimally invasive surgery.
Methods: From May 2011 to April 2013, a single operator attempted SITS for 264 cases. Their medical records were
retrospectively reviewed with regard to age, sex, diagnosis, operation time, hospital stay, need of additional incision,
morbidity, and early outcome.
Results: A number of thoracic diseases and procedures were attempted with SITS including primary (n = 172)
or secondary (n = 22) spontaneous pneumothorax, biopsy for lung (n = 29), pleura (n = 3), and mediastinal lymph
node (n = 3), mediastinal mass excision (n = 11), empyema decortication (n = 11), lobectomy (n = 6), pulmonary
metastasectomy (n = 3), pericardial window formation (n = 3), and hematoma evacuation (n = 1). Of these, 237 cases
underwent SITS successfully. However, additional incision was needed in 10.2% (n = 27). Reasons for conversions
were as follows: extensive pleural adhesion (n = 14), difficulty in endoscopic stapling (n = 11), bleeding (n = 1), and
intolerance of one lung ventilation (n = 1). Conversion rate of empyema was 54.5%, which was the most difficult
for SITS. In contrast, the conversion rate of PSP was 4.7%, which means PSP was the most applicable for SITS.
Postoperative complications included air leak (≥3 days) (n = 1), wound problem (n = 4), delayed pleural effusion
(n = 1), and postoperative bleeding (n = 1).
Conclusions: SITS can be a routine approach from simple to more complicated diseases. However, we still have
difficulties in cases with extensive pleural adhesion or location of lesion with difficult accessibility for endoscopic
stapling.
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Video-assisted thoracic surgery (VATS) has been performed
from the late 1980s. Since then, the technique has widened
its clinical indications for the past 20 years. Numerous
previous studies have already proved that VATS is more
advantageous in postoperative recovery, cosmesis and
also oncological aspect compared to the conventional
thoracotomy [1-4]. Furthermore, as surgical experi-
ences in VATS accumulated and instruments advanced,
there were attempts to perform single incision thoraco-
scopic surgery (SITS) as an alternative for the multiport* Correspondence: pda1052@gmail.com
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unless otherwise stated.VATS, and already a few studies have reported on the
safety and feasibility of SITS [5-10].
Our previous study has attested, by comparing SITS and
the conventional three-port VATS, that SITS can be applied
as a routine procedure in primary spontaneous pneumo-
thorax (PSP) patients. This was because SITS proved to de-
crease paresthesia of chest wall and increase satisfaction
rate for the wound scar with high reproducibility [10].
However, previous studies on SITS including our results
have reported on the basis of a small case series [5-7,9-14].
Currently, we are at the threshold where the technique
needs to collect more evidences to make grounds for wider
application of SITS.
In our hospital, we did not limit SITS in only PSP pa-
tients, but also actively performed in other thoracictd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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with successful 237 cases, which records as second high-
est number of cases reported by single operator until
now [15]. We reviewed our early experiences with the
use of SITS in the treatment of various thoracic diseases
and evaluated whether SITS can be a routine approach
in minimally invasive thoracic surgery.
Methods
In 2009, Rocco suggested the indications of SITS as a
general thoracic surgical practice [8]. In May 2011, we
first applied SITS when performing pulmonary wedge
resection in a patient with PSP. Since then, as Rocco had
suggested, we continued to widen surgical indications
with the accumulation of surgical experiences.
A single operator (HCY) at Seoul National University
Bundang Hospital performed 491 thoracic surgical pro-
cedures from May 2011 to April 2013 and the medical
records were reviewed retrospectively. SITS was prior
consideration for all VATS cases during the period.
There were 162 surgeries which had nothing to do with
VATS. Among the remaining 329 VATS procedures,
SITS was attempted in a total of 264 (264/329; 80.2%)
surgeries. We performed SITS in patients with primary
or secondary pneumothorax, well demarcated medias-
tinal mass, empyema, diffuse interstitial lung disease that
need lung biopsy, indeterminate peripheral pulmonary
nodule, parietal pleural nodule, pericardial effusion, me-
diastinal lymph node enlargement, bronchiectasis, asper-
gilloma, congenital abnormality of the lung and even
with primary lung cancer (Table 1). Although the sur-
gery was performed with VATS, 65 cases which did not
implement SITS in the first place were excluded. The
exceptions, where SITS could not be applied were as
below: pneumothorax patients with previous 3-port
VATS wound scar (n = 4), patients with pneumothorax
(n = 17) or empyema (n = 12) with large bore chest tube
in a position that was not appropriate for SITS, empy-
ema patients with peel of 10 mm or greater in the com-
puted tomography (CT) scan (n = 7), patients with
mediastinal tumor mass of greater than 9 cm (n = 2), pa-
tient with tumor located between the superior vena cava
and the innominate vein posing risks for the procedure
(n = 1), thymoma patients with myasthenia gravis (n = 2),
patient with diaphragmatic hernia (n = 1), patients with
compromised lung function before lung biopsy surgery
(n = 9), patient who scheduled VATS lobectomy and
other organ cooperative operation while minimizing
the operation time (n = 1), those who required finger
palpation of the mass when doing a wedge resection for
pulmonary nodule (n = 3), two or more locations of le-
sions that were difficult to access via SITS (n = 4), and
when the patients who required VATS lobectomy were
predicted to have anthracofibrotic lymph nodes in thepreoperative CT and bronchoscopy (n = 2). The collected
data were age, sex, diagnosis, operation time, hospital
stay, need of additional incision, postoperative com-
plications, and short-term outcome. This study was ap-
proved by Institutional Review Board of our institution
with waiver of informed consent (SNUBH ID: B-1206-
158-113).
Surgical technique
The patient was in a lateral decubitus position after in-
tubation with double lumen endotracheal tube. After
one lung ventilation, the location and length of the sin-
gle incision was decided according to the purpose of the
surgery. All the patients except those who underwent
lobectomy for lung cancer received a 2.5 cm or 3 cm
long skin incision, which was enough for the SITS tech-
nique to be applied. In case of lobectomy for lung can-
cer, the size of the lung specimen was needed to be
taken into consideration. Thus, we made a 4 to 5 cm
long incision in the mid-axillary line of the 5th intercos-
tal space (ICS). When approaching to the upper lobe
such as cases of PSP, the incision was made on the 5th
ICS in the mid-axillary line. However, when approaching
to the lower lobe, the 6th or 7th ICS in the anterior axil-
lary line was selected. If the patient had a previous
wound scar for VATS or closed thoracostomy, we ac-
tively utilized the site despite of surgeon’s discomfort.
The same pain control method was used in all the pa-
tients. Bupivacaine of 0.5% with 10 to 15 cc was injected
on the parietal pleura, muscle, and subcutaneous layer
before skin incision. Continuous-patient-controlled anal-
gesia was not used for pain control. We created small
utility window by placing wound retractor (XS U-
tractor™, YUWON MEDITECH, Wonju, Korea) to main-
tain air venting and block optical lens contamination by
intercostal muscle bleeding. In all cases, a 5.5-mm ex-
tended length HD Autoclavable thoracoscope, 30-degree
(Conmed, Utica, NY, USA) was used. We utilized the
flexible or long curved thin shaft instruments in order to
minimize conflicts between instruments and smoothly
carry out the procedures (Figure 1). We frequently chan-
ged between hook type and spatula type electrocautery
for hilar dissection as appropriate during the operation,
and used LigaSure™ (Covidien, Mansfield, MA, USA) if
necessary. In lobectomy cases, we divided pulmonary
vein and bronchus with endo-staplers. If the pulmonary
artery branch was less than 5 mm, we divided it using
the locking clips, but if the pulmonary artery was larger
than 5 mm, we used endo-stapler. Patients who under-
went lobectomy for lung cancer underwent systematic
lymph node dissection. For cases of pneumothorax, we
performed mechanical pleurodesis together with wedge
resection in the beginning. However, we are now rou-
tinely using fibrin glue coverage due to the side effects
Table 1 Indication of single incision thoracoscopic surgery
Type of thoracic disease Operation Additional incision Comment
Pneumothorax (n = 194) PSP (n = 172) Resection of blebs/bullae n = 8, 4.7%
SSP (n = 22) n = 4, 18.2%
Mediastinal tumor Thymic cyst (n = 4) Mass excision Neurogenic tumor
(n = 1, 9.1%)
Tumor size
Anterior (n = 7) Thymoma (n = 1) (R: 1.2-6.7 cm)
Posterior (n = 4) Pericardial cyst (n = 1)
Neurogenic tumor (n = 4)
Mature teratoma (n = 1)
Interstitial lung disease (n = 21) RUL (n = 3) Wedge resection n = 4, 19%
RML (n = 1) 1 site (n = 15) RLL 1
RLL (n = 5) 2 site (n = 6) RUL & RLL 1
LUL (n = 2) RML & RLL 1
LLL (n = 4) LUL & LLL 1
RUL & RLL (n = 2)
RML & RLL (n = 1)
LUL & LLL (n = 3)
Solitary pulmonary nodule (n = 5) RML (n = 1) Wedge resection n = 2, 40%
RLL (n = 2) RLL 1
LUL (n = 2) LUL 1
Empyema (n = 11) Non-TB (n = 10) Decortication n = 6, 54.5%
TB (n = 1)
Mediastinal 4R (n = 1) Lymph node biopsy n = 2, 66.7% Reason: bleeding
lymphadenopathy (n = 3) 5 (n = 1) LN location
6,7 (n = 1)
Pleural seeding and/or pulmonary
metastases (n = 6)
Lung cancer (n = 3) Biopsy of parietal pleura and/
or pleurodesis Biopsy of lung
0
Metastases (n = 3)
Pericardial effusion (n = 3) Unknown etiology (n = 1) Pericardial window formation 0 6th ICS approach, left
Post CT (n = 1)
Postoperative (n = 1)
Lung cancer (n = 3) RUL (n = 2) Lobectomy & mediastinal
LN dissection
0 4-5 cm skin incision
RLL (n = 1)
Inflammatory lung disease (n = 6) Lobectomy 0 2.5 cm skin incision
Bronchiectasis (n = 1) :LLL




Tuberculosis (n = 3) Biopsy of lung
Postoperative bleeding (n = 1) Hematoma evacuation 0 Due to mechanical pleurodesis
PSP, Primary Spontaneous Pneumothorax; SSP, Secondary Spontaneous Pneumothorax; R, range; TB, Tuberculosis; LN, Lymph node; ICS, Intercostal space;
CT, Chemotherapy.
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paresthesia, and the risk of bleeding.
Empyema decortication was performed for fibrino-
purulent or organized stage after chest tube drainage
treatment had failed to achieve the desired results. We
aimed to drain the exudative fluid and remove theempyema sac and thickened peel to restore lung expan-
sion. Successful cases of empyema decortication by SITS
were those that had good peel removal at an appropriate
time point.
If a second port is required due to extensive pleural
adhesion, a 3 cm length of utility window was made to
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endo-stapling, an additional port was made to allow the
easy stapling movement with the size of 1.5 cm.
One chest tube (20 or 24 french chest tube) was
inserted through one end of the single incision (Figure 2).
Exceptionally, in the case of empyema, we inserted two
chest tubes through each end of the incision.
The decision to remove the chest tube was made by
the following criteria: the lungs fully expanded and if
there is no pleural effusion in the chest x-ray; there is no
air leakage through the chest tube; the amount of drain-
age is less than 150 cc per day. In the cases of pneumo-
thorax, most patients had chest tube removal on
postoperative day 1 and discharged on that day after
confirming the postprocedural chest x-ray.
Statistical analysis
Data were analyzed with SPSS 18.0 software program
(Statistical Package for Social Sciences, SPSS Inc., Chicago,
IL, USA). Continuous variables were presented as median
value with range.
Results
SITS was attempted in 257 patients. Seven of these patients
underwent surgery twice; so a total of 264 cases of SITSFigure 1 Instruments for single incision thoracoscopic surgery.were tried. A number of thoracic diseases and procedures,
including PSP (n = 172), secondary spontaneous pneumo-
thorax (SSP) (n = 22), lung biopsy (n = 29), lobectomy
(n = 6), mediastinal mass excision (n = 11), empyema decor-
tication (n = 11), pulmonary metastasectomy (n = 3), medi-
astinal lymph node (LN) biopsy (n = 3), pericardial window
formation (n = 3), pleural biopsy with talc pleurodesis
for malignant pleural effusion (n = 3), and postoperative
hematoma evacuation (n = 1), were attempted with SITS.
Among them, SITS was performed successfully in 237
cases (89.8%) without additional incision.
The median age was 23 years old (range: 12–86) and
the median operation time was 75.5 minutes (range: 30–
285). The median postoperative hospital stay was 2 days
(range: 1–37), and the median follow-up duration was
5.1 months (range: 0.1-24) (Table 2). In 27 cases (10.2%)
additional incisions were needed. The reasons of add-
itional incision were as follows: extensive pleural adhe-
sion (n = 14, 5.3%), difficulty in approaching with an
endoscopic stapler (n = 11, 4.1%), bleeding (n = 1, 0.4%),
intolerance of one lung ventilation (n = 1, 0.4%) (Table 3).
Conversion rate of empyema was 54.5%, which was the
most difficult disease entity applied to SITS. In contrast,
the conversion rate of PSP was 4.7%, which means PSP
was the most applicable for SITS. All lobectomies (n = 6)
were performed without additional incision.
Figure 2 Single port right upper lobectomy with only 2.5 cm
skin incision.
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toperative hospital stay, postoperative complication, fol
low-up period, early outcome according to each SITS
procedure. Operation time and hospital stay in the
patients with simple pulmonary wedge resection in-
cluding pneumothorax, interstitial lung disease, or soli-
tary pulmonary nodule were shorter than other SITS
procedures. In contrast, lobectomy showed the longest
operation time, and decortication patients had the lon-
gest hospital stay. Postoperative complication occurred
in 7 (7/237 = 2.95%) patients. One PSP patient underwent
hematoma evacuation due to postoperative bleeding
from parietal pleura after pulmonary wedge resection
and mechanical pleurodesis. One patient had air leakage
for more than 3 days. Two patients had wound dehis-
cence, which was solved with skin stapler. One patient
who underwent left lower lobectomy readmitted due to
increased pleural effusion and was treated with 12 French
mini-chest tube insertion. One PSP patient with bilateral
multiple bullae had wound infection and contamination of
thoracic cavity after receiving operation on both sides.
This patient was originally transferred to our hospital on
the 7th day of chest tube insertion from the other hospital
because he had prolonged air leakage with moderate sub-
cutaneous emphysema. We believe this may have led toTable 2 Patients characteristics
Variables SITS (n = 237)
Sex (M/F) 175/55
Age, years 22 (12–86)
Operation time, min 73 (30–260)
Hospital stay, days 2 (1–36)
Follow-up period, months 4.4 (0.1-24)
Continuous variables were presented as median value with range.
SITS, Single Incision Thoracoscopic Surgery; M, male; F, female; min, minute.bacterial infection carried from the previous chest tube
insertion site. SITS irrigation was performed on bilateral
thoracic cavities on postoperative day (POD) 6 and dis-
charged without any other problem on POD 8 of redo-
SITS. Another PSP patient was diagnosed with wound
infection on POD 19 in outpatient visit. Wound infection
was treated with simple dressing for 4 days.
During the follow-up of the patients with PSP and SSP
with median 5.1 months (range: 0.1-24), there were 10
pneumothorax recurrences (5.2%). Two patients under-
went reoperation, four patients recovered after fibrin
pleurodesis via chest tube. The remaining 4 patients had
minimal sign of pneumothorax, which needed just ob-
servation. There was no recurrence in the patients with
empyema and lung cancer.
Discussion
Most of the published studies are only case reports or
papers outlining how to perform SITS [5-7,9,10,12,14].
Also comparative studies with the conventional 3-port
VATS were performed in the aspects of the safety and
efficacy only in a small case series [5,7]. Recently,
Gonzales, who has most experience with SITS, reported
97 patients undergoing uniportal VATS lobectomy [6].
This study was set up to assess whether SITS can be
acceptable as the routine procedure in the thoracic sur-
gery. A large scale of our study suggests SITS can be a
safe and feasible alternative for the conventional 3-port
VATS. The major obstacles of SITS were the extensive
pleural adhesion and access difficulty for pulmonary
wedge resection with endoscopic stapler.
We have first introduced the SITS technique in PSP
patients. Since then SITS was considered as a routine
procedure in all pneumothorax patients including SSP.
We recommend the PSP as the first possible surgical
consideration for SITS. This is because this disease has
no pleural adhesion problems, and the blebs or bullae
usually develop at apical portion of upper lobe alongside
the coronal plane, which starts from the apicolateral
portion of the upper lobe to the medial side. The dis-
tinctive feature of this disease makes wedge resection
possible without hindrance. In other words, the stapler
is inserted through the 5th ICS in the mid-axillary line,Conversion (n = 27) Total (n = 264)
18/9 193/64
57 (15–81) 23 (12–86)
114 (45–285) 75.5 (30–285)
3 (1–37) 2 (1–37)
9.2 (1.5-20.1) 5.1 (0.1-24)
Table 3 Reasons for additional incision
Reason Empyema ILD/SPN PSP SSP Mediastinal tumor Mediastinal LN enlargement Total (n = 27)
Pleural adhesion 5 4 3 1 1 NA 14
Location of lesion 1 1 5 3 NA 1 11
Bleeding NA NA NA NA NA 1 1
Difficult one lung ventilation NA 1 NA NA NA NA 1
ILD, Interstitial Lung Disease; SPN, Solitary Pulmonary Nodule; PSP, Primary Spontaneous Pneumothorax; SSP, Secondary Spontaneous Pneumothorax; LN, Lymph
Node; NA, Not Applicable.
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eral to the medial side around the apical portion of the
upper lobe. These clinical experiences helped us broaden
application of SITS not only in pulmonary wedge resec-
tion, but also in mediastinal mass excision, lung/LN/
pleural biopsy, empyema decortication, pericardial win-
dow formation, and lobectomy. Moreover, through the
accumulation of these experiences, SITS is demonstrated
as a safe and feasible method that can be selected as a
routine procedure.
As stated previously, SITS was performed mostly in
both PSP and SSP. Currently, SITS has become the most
preferred method in the pneumothorax surgery. The con-
version rate from SITS to 2-port VATS for PSP and SSP
was 6.2% (12/194). However, such conversion mainly oc-
curred in the initial learning period due to lesion location
(n = 8) and pleural adhesions (n = 4). Currently, SITS is
being carried out with very little conversions. With regards
to pleural adhesiolysis, the use of SILS™ HOOK (Covidien,
Mansfield, MA, USA) proved to be very useful.
Some PSP patients had two incisions despite of SITS
technique because we could not utilize initial chest tube
insertion site located on the 6th or 7th ICS, which was
made in the Emergency Department. These days, resi-
dents are instructed to perform chest tube insertionTable 4 Comparisons among major operative methods in SIT




Median age, years 19 (14–79) 61.5
Median Operation time, min 75.5 (34–208) 64.5
Median postoperative hospital stay, day 2 (1–14) 4 (1–




Infection (n = 2)
Bleeding (n = 1)
Median F/U period, month 5.1 (0.1–24) 5.35
Early outcome (recurrence) 10 (5.2%)
*Others included interstitial lung disease, solitary pulmonary nodule, pulmonary me
PNX, Pneumothorax; min, minute; F/U, follow up; NED, No evidence of disease.properly, with consideration to the possibility of SITS
later. With this, we are carefully attending to reduce the
unnecessary scars endured by patients.
As seen in our results, the second biggest reason for
the need of additional incision was the difficulty in
accessing the lesion for endoscopic stapler. To overcome
this, proper incision location is very important for SITS.
We were able to reduce the conversion rate via making
the small utility window based on the purpose of surgery
and location of lesions. In the case of wedge resection
on the upper lobe or superior segment of the lower lobe,
it is better to locate the incision on the 5th ICS mid-
axillary line. In case of wedge resection on basal portion
of the lower lobe, the 6th or 7th ICS in the anterior axil-
lary line is appropriate. Although it may be different
based on patients’ condition, in case of wedge resection,
the incision for the port should be made 6-7 cm apart
from the lesion in order to use a 60 mm length stapler.
If it is difficult to obtain the stated distance, using a
45 mm length stapler may be useful.
Based on the type of disease, empyema decortication had
higher conversion rate (6/11, 54.5%) because safely dissect-
ing the extensive pleural adhesion via single port was diffi-
cult. In case of extensive and tight pleural adhesion, like
empyema, 2 or 3-port VATS is better suited than SITS.S
ge resection,






excision (n = 11)
(34–86) 50 (12–66) 59 (38–77) 45 (13–69)
(30–165) 219 (160–260) 175 (84–285) 93 (39–175)




(0.8–18.4) 2.55 (0.3–9.4) 3.6 (1.5–12.6) 6.8 (0.7–22.7)
NED NED NED
tastases and tuberculosis.
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vious studies, a single port lobectomy was possible on
the 5th ICS in anterior to mid axillary line [6] (Figure 2).
Since it was easier to access the hilar structure, we were
able to quickly get accustomed. In the 3 cases of lung
cancer, 4-5 cm of skin incision was necessary to extract
lobar specimen without injury. In other 3 patients who
underwent lobectomy for benign lung disease, including
bronchiectasis, aspergilloma, and congenital lobar em-
physema, the skin incision was minimized to only
2.5 cm. On our first case of a 2.5 cm lobectomy, we cut
the lobe into 3 pieces in a specimen bag with scissors.
However, on our second and third cases, a 2.5 cm skin
incision was successfully used to extract the lobar speci-
men without significant injury. Thereafter, we realized
that in cases with benign diseases without a mass, even
with a 2.5 cm skin incision, it is possible to extract the
lobe without the damages to the lung.
Some authors defined that length of single port was less
than 3.5 cm [16]. But there is no consensus on the length
of single incision to be considered as SITS. The factors that
determine the length of skin incision are the size of the spe-
cimen and whether the stapler is used or not. From our ex-
perience, 2.5 cm was the minimum incision length when
stapling was needed. However, 2 cm was enough when
stapling was not needed.
For successful outcome of SITS, it is essential to prop-
erly set the equipment for SITS. We used a wound re-
tractor to maintain the utility window to prevent optical
lens blood contamination from the chest wall muscle
and to eliminate smoke from electrocautery. In regard of
preventing instrument conflict, long and narrow shaft,
and curved or flexible instruments were seemed to be
helpful. In the future, if curved and smaller stapler is
developed, the applicability of SITS will be expanded.
The advantages of SITS over the 3-port VATS are less
pain, less paresthesia, and higher satisfaction rate for
wound scar [5-12,14,16]. Despite of these advantages, there
are still very limited numbers of surgeons who perform
SITS. However, many young surgeons express great inter-
est in learning the application of SITS in various diseases.
Although we only had 6 lobectomy cases, we have the large
number of experiences with SITS for various diseases.
We believe that this study will help those who seek to
start incorporating SITS as a routine approach.
Cosmesis is an important aspect of SITS. In order to
reduce wound problem, we minimize electrocauterization
on chest wall muscles to make a single port, which helps
the spontaneous approximation of the muscle layer in the
site of chest tube after removal of the chest tube. We also
use 20 or 24 Fr. chest tube and do our best to shorten the
chest tube indwelling time. Skin bond is an effective pre-
vention for wound dehiscence. These efforts have helped
us overcome the wound problems.There are a few limitations to our study. First, the follow-
up period is relatively short because it has been only
24 months since SITS was performed at our hospital. Thus,
long-term follow up data for recurrences of pneumothorax
or oncologic results in lung cancer patients are not enough.
Second, a majority of the patients (165/257, 64.2%) were di-
agnosed with PSP. Hence, further cases should be per-
formed around other disease entities. This is because the
surgeries were carried out by a single operator (HCY), who
is mainly in charge of benign thoracic diseases. However,
two hundred fifty seven patients underwent SITS during
24 months. This was possible because the operator consid-
ered SITS as the first routine procedure for the thoracic pa-
tients. Third, this is not a comparative study with 3-port
VATS. Therefore, there is no evidence to demonstrate SITS
as a superior method compared to the conventional VATS.
However, in our experience, the SITS sufficiently satisfied
what the conventional 3-port VATS has aimed. In addition,
it involves only one intercostal space with minimal skin
incision, which means SITS is the most minimally invasive
surgery known until today. To prove the advantages of
SITS more clearly compared to 3-port VATS, a multicen-
ter, large-scale randomized controlled study should be
performed in the near future.
Conclusions
In conclusions, for successful SITS, well-equipment, loca-
tion of port, experiences in simple thoracic procedures and
harmony with surgical assistants are necessary. SITS is con-
sidered as a safe, feasible and reproducible procedure in
variety of thoracic diseases. However, in case of extensive
pleural adhesion, as in empyema, or location of lesion with
difficult accessibility for stapling, additional incisions may
be safer for patients.
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